or Try an Advanced Search...

    Technical Analysis for CMB - Cambium Bio Limited

    Grade Last Price % Change Price Change
    F 0.400 9900.00% 0.396
    CMB closed down 20.0 percent on Monday, July 1, 2024, on 12 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A N/A Down
    Historical CMB trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish -20.00%
    Lizard Bullish Bullish Day Trade Setup -20.00%
    Older End-of-Day Signals for CMB ...

       Recent Intraday Alerts

    Alert Time
    Down 10% 5 days ago
    Down 2 ATRs 5 days ago
    Down 1 ATR 5 days ago
    Down 5% 5 days ago
    Down 3% 5 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CMB Chart by TradingView
    Basic chart:

    Profile

    Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. The company's platform technology includes Progenza, a multi-synergistic therapy, which has completed Phase I clinical trial for the treatment of osteoarthritis; and in pre-clinical stage to treat neuropathic pain. It also develops Sygenus that is in pre-clinical stage for the treatment of skin wound healing. The company was incorporated in 2007 and is headquartered in Paddington, Australia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Platform Technology Regenerative Medicine Aging Associated Diseases Arthritis Dermatology Diseases Musculoskeletal Disorders Osteoarthritis

    Is CMB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.9
    52 Week Low 0.4
    Average Volume 1,749
    200-Day Moving Average 0.000
    50-Day Moving Average 0.000
    20-Day Moving Average 0.580
    10-Day Moving Average 0.510
    Average True Range 0.050
    RSI (14) 45.65
    ADX 15.97
    +DI 31.746
    -DI 41.270
    Chandelier Exit (Long, 3 ATRs) 0.550
    Chandelier Exit (Short, 3 ATRs) 0.550
    Upper Bollinger Bands 0.760
    Lower Bollinger Band 0.400
    Percent B (%b) 0.0
    BandWidth 62.069
    MACD Line -0.070
    MACD Signal Line -0.050
    MACD Histogram -0.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.400
    Resistance 3 (R3) 0.400 0.400 0.400
    Resistance 2 (R2) 0.400 0.400 0.400 0.400
    Resistance 1 (R1) 0.400 0.400 0.400 0.400 0.400
    Pivot Point 0.400 0.400 0.400 0.400 0.400
    Support 1 (S1) 0.400 0.400 0.400 0.400 0.400
    Support 2 (S2) 0.400 0.400 0.400 0.400
    Support 3 (S3) 0.400 0.400 0.400
    Support 4 (S4) 0.400